FKBP14 and Ehlers-Danlos syndrome: FKBP22 shows substrate specificity as it binds collagen III (and VI and X) but not collagen I, II or V [23], but appears to act post prolyl hydroxylation (see below) [24], and mutations in or absence of FKBP22 cause Kyphoscoliotic EDS [2].